Cetrocare 0.25mg Injection
Marketer
Gufic Bioscience Ltd
Salt Composition
Cetrorelix (0.25mg)
Overview Cetrocare 0.25mg Injection
Cetrocare 0.25mg Injection, a gonadotropin-releasing hormone antagonist, treats female infertility. It suppresses egg release, preventing premature ovulation. Administered subcutaneously by a healthcare professional, self-injection is strictly prohibited. Your doctor or nurse will provide guidance on proper home injection technique. Dosage and frequency are individualized and determined by your physician to optimize treatment. Continue using the medication as prescribed. Common side effects include injection site reactions (redness, itching, irritation), nausea, and vomiting. Rotate injection sites on the abdomen daily to minimize irritation. Seek immediate medical attention for dizziness, fainting, abdominal pain, or severe vomiting. Prior to treatment, disclose any history of liver or kidney disease, or breastfeeding. Inform your doctor about all other medications you are currently using, as interactions may affect Cetrocare's efficacy or action.
Primary Ingredients of Cetrocare 0.25mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Cetrocare 0.25mg Injection
Inability to conceive in women
Major Benefits of Cetrocare 0.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cetrocare 0.25mg Injection:
- Nausea
- Ovarian hyperstimulation syndrome
- Injection site reactions (pain, swelling, redness)
- Itching
- Irritation
- Vomiting
- Lower abdominal pain
How to use Cetrocare 0.25mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Cetrocare 0.25mg Injection works:
During infertility treatment in women, the premature discharge of immature eggs, unsuitable for fertilization, can occur. Cetrocare 0.25mg Injection inhibits a naturally occurring hormone, thereby preventing this premature ovarian egg release.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining alcohol and Cetrocare 0.25mg Injection. Seek medical advice before doing so.
PregnancyUNSAFE
Administering Cetrocare 0.25mg Injection during pregnancy poses a substantial risk. Pregnant individuals should consult their physician; research in animal and human studies has revealed significant adverse effects on fetal development.
Breast feedingUNSAFE
Administration of Cetrocare 0.25mg Injection is contraindicated while breastfeeding due to potential infant toxicity indicated by available data.
DrivingSAFE
Driving ability is typically unaffected by Cetrocare 0.25mg Injection.
KidneyCAUTION
Patients with kidney impairment should use Cetrocare 0.25mg Injection cautiously, potentially requiring a modified dosage. Medical advice is essential. Cetrocare 0.25mg Injection is contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Cetrocare 0.25mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Cetrocare 0.25mg Injection :
Omit a Cetrocare 0.25mg Injection dose? Seek medical advice immediately.
Facts to Know About Cetrocare 0.25mg Injection
| Label | Value |
|---|---|
| Chemical Type | Protein chains |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Behavioral Class | GnRH receptor blockers |
3,018 People bought this recently